Anduril

$250M Pentagon contract for 500 Roadrunner interceptors plus Pulsar EW validates product-market fit in counter-UAS and provides near-term revenue anchor (Defense News, Jan 2025)

Arsenal-1 in Ohio (~1.7M sq ft across two buildings) with Fury CCA production targeted for 2Q26 represents credible commitment to high-rate manufacturing at unprecedented scale for a defense startup (Defense Daily, 2026; Columbus Dispatch, 2026)

Rhode Island AUV factory targeting >200 AUVs/year (up from 12 hulls/year at Quincy) diversifies revenue beyond C-UAS into strategically critical undersea autonomy, backed by $18.6M Navy contract (Janes, 2024)

Lattice platform selected by U.S. Space Force for surveillance networks and by DIU for RCV software frameworks, demonstrating cross-domain applicability and potential for recurring software revenue (Wikipedia)

Series F of $1.5B at $14B valuation (CNBC, Aug 2024) with reported subsequent $2.5B raise signals strong investor confidence and provides capital runway for industrial scale-up

Strategic acquisitions (Area-I for ALTIUS, Dive Technologies for AUVs, Copious Imaging) have been purposeful and are bearing fruit in expanded product lines and production plans

Manufacturing ramp from prototype to 'tens of thousands' per year at Arsenal-1 is unprecedented for a company of this age; any schedule slip from mid-2026 targets would ripple through revenue and credibility (Defense Daily; Columbus Dispatch)

CCA program (Fury/YFQ-44A) faces competitive downselect risk as one of five USAF vendors; budget constraints and program-of-record conversion remain uncertain (Wikipedia)

Valuation claims are highly inconsistent across third-party sources ($14B verified in 2024 vs. $30.5B, $60B, and $79.6B from aggregators), creating information asymmetry and potential down-round risk (CNBC; Premier Alts; Caproasia)

Chinese sanctions (July 2024) introduce geopolitical friction, potential supply chain vulnerabilities, and may constrain international market access (Wikipedia)

Revenue figures (~$1B in 2024 per Wikipedia) and employee counts (~3,500) lack independent verification from audited filings, making financial assessment difficult for a private company

Export control constraints could limit the international sales opportunity for counter-UAS and autonomous systems, capping total addressable market growth

Arsenal-1 production ramp execution: achieving rate production by mid-2026 requires flawless supply chain orchestration, workforce scaling, and quality systems with no margin for delay

CCA downselect risk: Fury must win competitive selection against established primes and other vendors to become a program of record with multi-year funding

Valuation inflation: private market valuations ranging from $14B to $79.6B across sources create significant uncertainty; overextension could lead to down-round risk if program outcomes disappoint

Geopolitical exposure: Chinese sanctions and export controls could constrain supplier access, international sales, and create cyber/IP risks

Customer concentration: heavy reliance on U.S. DoD procurement budgets and rapid acquisition pathways that may not convert to enduring programs of record

Private company opacity: lack of audited financials, verified revenue, and backlog data limits investor ability to assess true financial health

Arsenal-1 Fury production line start in 2Q26 and broader drone/AAV production beginning July 2026 — the single most important near-term execution milestone

USAF CCA downselect decisions that could position Fury as a program of record with multi-year, multi-billion dollar procurement potential

Follow-on Roadrunner/Pulsar orders beyond the initial 500-unit buy, potentially including international sales to allied nations

Rhode Island AUV factory reaching operational capacity (>200 AUVs/year), validating undersea autonomy as a second major revenue pillar

Potential IPO or verified mega-round ($8B at $60B reported by Caproasia) that would provide financial transparency and liquidity